The Inhibition of KCa3.1 Channels Activity Reduces Cell Motility in Glioblastoma Derived Cancer Stem Cells

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Ruggieri, Paola ^a   Mangino, Giorgio ^a   Fioretti, Bernard ^b   Catacuzzeno, Luigi ^b   Puca, Rosa ^a   Ponti, Donatella ^a   Miscusi, Massimo ^a   Franciolini, Fabio ^b   Ragona, Giuseppe ^a   Calogero, Antonella ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 [(2 CHLOROPHENYL)DIPHENYLMETHYL] 1H PYRAZOLE; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; KCA3.1 CHANNEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL MOTILITY; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POTASSIUM CURRENT; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; FLUORESCENT ANTIBODY TECHNIQUE; GLIOBLASTOMA; HUMANS; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MICE; NEOPLASTIC STEM CELLS; PATCH-CLAMP TECHNIQUES; PYRAZOLES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84867706193     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047825     Document Type: Article

References (57)

1. Qiang L, Yang Y, Ma YJ, Chen FH, Zhang LB, et al. (2009) Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. Cancer Lett 279: 13-21.
2. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS, (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4: 278-299.
3. Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M (2006) Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2: 494-503; quiz 491 p following 516.
4. Sanai N, Berger MS (2008) Glioma extent of resection and its impact on patient outcome. Neurosurgery 62: 753-764; discussion 264-756.
5. Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, et al. (2008) Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113: 1953-1968.
6. Schönherr R, (2005) Clinical relevance of ion channels for diagnosis and therapy of cancer. J Membr Biol 205: 175-184.
7. Sontheimer H, (2008) An unexpected role for ion channels in brain tumor metastasis. Exp Biol Med (Maywood) 233: 779-791.
8. Stühmer W, Pardo LA, (2010) K(+) channels as therapeutic targets in oncology. Future Med Chem 2: 745-755.
9. Olsen ML, Sontheimer H, (2004) Mislocalization of Kir channels in malignant glia. Glia 46: 63-73.
10. Bubien JK, Keeton DA, Fuller CM, Gillespie GY, Reddy AT, et al. (1999) Malignant human gliomas express an amiloride-sensitive Na+ conductance. Am J Physiol 276: C1405-1410.
11. Ransom CB, O'Neal JT, Sontheimer H, (2001) Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells. J Neurosci 21: 7674-7683.
12. Liu X, Chang Y, Reinhart PH, Sontheimer H, (2002) Cloning and characterization of glioma BK, a novel BK channel isoform highly expressed in human glioma cells. J Neurosci 22: 1840-1849.
13. Logsdon NJ, Kang J, Togo JA, Christian EP, Aiyar J, (1997) A novel gene, hKCa4, encodes the calcium-activated potassium channel in human T lymphocytes. J Biol Chem 272: 32723-32726.
14. Ishii TM, Silvia C, Hirschberg B, Bond CT, Adelman JP, et al. (1997) A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci U S A 94: 11651-11656.
15. Weaver AK, Bomben VC, Sontheimer H, (2006) Expression and function of calcium-activated potassium channels in human glioma cells. Glia 54: 223-233.
16. Fioretti B, Castigli E, Micheli MR, Bova R, Sciaccaluga M, et al. (2006) Expression and modulation of the intermediate- conductance Ca2+-activated K+ channel in glioblastoma GL-15 cells. Cell Physiol Biochem 18: 47-56.
17. Abdullaev IF, Rudkouskaya A, Mongin AA, Kuo YH, (2010) Calcium-activated potassium channels BK and IK1 are functionally expressed in human gliomas but do not regulate cell proliferation. PLoS One 5: e12304.
18. Wu CY, Hung JJ, Wu KJ (2011) Linkage between Twist1 and Bmi1: molecular mechanism of cancer metastasis/stemness and clinical implications. Clin Exp Pharmacol Physiol.
19. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, et al. (2000) Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 97: 14720-14725.
20. Lombari V, De Gregorio G, Porcellini A, Calogero A, Arcella A, et al. (2002) Isolation of a glioblastoma cell line showing pluripotent phenotypic features. Fifth European Meeting on Glial Cell Function in Health and Disease. Rome. S30.
21. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
22. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, et al. (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645-648.
23. Bonnet D, Dick JE, (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737.
24. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
25. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, et al. (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64: 7011-7021.
26. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, et al. (2007) Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 104: 10158-10163.
27. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, et al. (2008) Identification of cells initiating human melanomas. Nature 451: 345-349.
28. Reya T, Morrison SJ, Clarke MF, Weissman IL, (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
29. Vescovi AL, Galli R, Reynolds BA, (2006) Brain tumour stem cells. Nat Rev Cancer 6: 425-436.
30. Rosen JM, Jordan CT, (2009) The increasing complexity of the cancer stem cell paradigm. Science 324: 1670-1673.
31. Heddleston JM, Li Z, Lathia JD, Bao S, Hjelmeland AB, et al. (2010) Hypoxia inducible factors in cancer stem cells. Br J Cancer 102: 789-795.
32. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760.
33. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, et al. (2006) Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66: 7843-7848.
34. Lee EK, Han GY, Park HW, Song YJ, Kim CW, (2010) Transgelin promotes migration and invasion of cancer stem cells. J Proteome Res 9: 5108-5117.
35. Huang Z, Cheng L, Guryanova OA, Wu Q, Bao S, (2010) Cancer stem cells in glioblastoma-molecular signaling and therapeutic targeting. Protein Cell 1: 638-655.
36. Bozzuto G, Ruggieri P, Molinari A, (2010) Molecular aspects of tumor cell migration and invasion. Ann Ist Super Sanita 46: 66-80.
37. Cuddapah VA, Sontheimer H, (2011) Ion channels and transporters [corrected] in cancer. 2. Ion channels and the control of cancer cell migration. Am J Physiol Cell Physiol 301: C541-549.
38. Schwab A, Gabriel K, Finsterwalder F, Folprecht G, Greger R, et al. (1995) Polarized ion transport during migration of transformed Madin-Darby canine kidney cells. Pflugers Arch 430: 802-807.
39. Sciaccaluga M, Fioretti B, Catacuzzeno L, Pagani F, Bertollini C, et al. (2010) CXCL12-induced glioblastoma cell migration requires intermediate conductance Ca2+-activated K+ channel activity. Am J Physiol Cell Physiol 299: C175-184.
40. Catacuzzeno L, Aiello F, Fioretti B, Sforna L, Castigli E, et al. (2011) Serum-activated K and Cl currents underlay U87-MG glioblastoma cell migration. J Cell Physiol 226: 1926-1933.
41. Li GR, Deng XL, (2011) Functional ion channels in stem cells. World J Stem Cells 3: 19-24.
42. Khanna R, Roy L, Zhu X, Schlichter LC, (2001) K+ channels and the microglial respiratory burst. Am J Physiol Cell Physiol 280: C796-806.
43. Van Renterghem C, Vigne P, Frelin C, (1995) A charybdotoxin-sensitive, Ca(2+)-activated K+ channel with inward rectifying properties in brain microvascular endothelial cells: properties and activation by endothelins. J Neurochem 65: 1274-1281.
44. Engbers JD, Anderson D, Asmara H, Rehak R, Mehaffey WH, et al. (2012) Intermediate conductance calcium-activated potassium channels modulate summation of parallel fiber input in cerebellar Purkinje cells. Proc Natl Acad Sci U S A 109: 2601-2606.
45. Longden TA, Dunn KM, Draheim HJ, Nelson MT, Weston AH, et al. (2011) Intermediate-conductance calcium-activated potassium channels participate in neurovascular coupling. Br J Pharmacol 164: 922-933.
46. Bouhy D, Ghasemlou N, Lively S, Redensek A, Rathore KI, et al. (2011) Inhibition of the Ca2+-dependent K+ channel, KCNN4/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury. J Neurosci 31: 16298-16308.
47. Catacuzzeno L, Fioretti B, Franciolini F, (2012) Expression and Role of the Intermediate-Conductance Calcium-Activated Potassium Channel KCa3.1 in Glioblastoma. J Signal Transduct 2012: 421564.
48. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T, (2005) Opinion: migrating cancer stem cells- an integrated concept of malignant tumour progression. Nat Rev Cancer 5: 744-749.
49. Rooj AK, McNicholas CM, Bartoszewski R, Bebok Z, Benos DJ, et al. (2012) Glioma-specific cation conductance regulates migration and cell cycle progression. J Biol Chem 287: 4053-4065.
50. Calogero A, Arcella A, De Gregorio G, Porcellini A, Mercola D, et al. (2001) The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Clin Cancer Res 7: 2788-2796.
51. Calogero A, Lombari V, De Gregorio G, Porcellini A, Ucci S, et al. (2004) Inhibition of cell growth by EGR-1 in human primary cultures from malignant glioma. Cancer Cell Int 4: 1.
52. Messina S, Frati L, Leonetti C, Zuchegna C, Di Zazzo E, et al. (2011) Dual-specificity phosphatase DUSP6 has tumor-promoting properties in human glioblastomas. Oncogene 30: 3813-3820.
53. D'Onofrio M, Arcella A, Bruno V, Ngomba RT, Battaglia G, et al. (2003) Pharmacological blockade of mGlu2/3 metabotropic glutamate receptors reduces cell proliferation in cultured human glioma cells. J Neurochem 84: 1288-1295.
54. Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, et al. (2003) Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med 9: 453-457.
55. Fioretti B, Catacuzzeno L, Sforna L, Aiello F, Pagani F, et al. (2009) Histamine hyperpolarizes human glioblastoma cells by activating the intermediate-conductance Ca2+-activated K+ channel. Am J Physiol Cell Physiol 297: C102-110.
56. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, et al. (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90: 5002-5012.
57. Piechaczek C, (2001) CD133. J Biol Regul Homeost Agents 15: 101-102.